A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Treatment of Biliary Systemic Tumours

NCT05644392 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Advanced Biliary Systemic Tumours That Has Failed at Least One Prior Systemic Therapy

Interventions

DRUG: Cadonilimab Injection
DRUG: Regorafenib

Sponsor

Tianjin Medical University Cancer Institute and Hospital